Heart disease is an umbrella term which encompasses a range of disorders such as heart attacks, congenital heart diseases, congestive heart failure and coronary artery disease. Heart disease is the number one cause for death in both men and women in the US. CT scans of mummies have shown that heart disease was frequent in Ancient Egypt which suggests that there are other causes to heart disease apart from smoking, fast food and inactivity.1
Last week, there was a brand new report released by the Quintiles IMS Institute on behalf of the Generic Pharmaceutical Association (GPhA), detailing the latest figures relating to the generic drugs space. The report, ‘2016 Generic Drug Savings and Access in the United States’, underlines the continued importance of the role of generic drugs in ensuring that patients are able to access treatment at an affordable cost. The report reveals that 3.9 billion of the total 4.4 billion prescriptions dispensed in the United States are for generic pharmaceuticals. While generics represent 89% of prescriptions dispensed, they account for only 27% of total medicine spending.